Cargando…
Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481585/ https://www.ncbi.nlm.nih.gov/pubmed/32953473 http://dx.doi.org/10.21037/tlcr.2020.04.05 |
| _version_ | 1783580636597977088 |
|---|---|
| author | Castellano, Gina M. Pine, Sharon R. |
| author_facet | Castellano, Gina M. Pine, Sharon R. |
| author_sort | Castellano, Gina M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7481585 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74815852020-09-17 Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? Castellano, Gina M. Pine, Sharon R. Transl Lung Cancer Res Editorial AME Publishing Company 2020-08 /pmc/articles/PMC7481585/ /pubmed/32953473 http://dx.doi.org/10.21037/tlcr.2020.04.05 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Castellano, Gina M. Pine, Sharon R. Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? |
| title | Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? |
| title_full | Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? |
| title_fullStr | Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? |
| title_full_unstemmed | Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? |
| title_short | Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? |
| title_sort | liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481585/ https://www.ncbi.nlm.nih.gov/pubmed/32953473 http://dx.doi.org/10.21037/tlcr.2020.04.05 |
| work_keys_str_mv | AT castellanoginam liquidbiopsiesinnonsmallcelllungcancermanagementwhatcanwelearnfrommethylationstatusandmutantallelefrequencies AT pinesharonr liquidbiopsiesinnonsmallcelllungcancermanagementwhatcanwelearnfrommethylationstatusandmutantallelefrequencies |